Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1988 Nov 12;297(6658):1227–1230. doi: 10.1136/bmj.297.6658.1227

Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction.

J M Cruickshank 1
PMCID: PMC1834729  PMID: 3145062

Abstract

The results of several large studies of hypertension and follow up studies on insured people have indicated that the lower the blood pressure the better for longevity. These studies excluded subjects with overt ischaemia. More recently long term studies of hypertension that included patients with more severe forms of hypertension and did not exclude those with overt ischaemia have shown a J shaped relation between diastolic blood pressure during treatment and myocardial infarction; the lowest point (the J point) was at a diastolic blood pressure (phase V) between 85 and 90 mm Hg. The J curve seems to be independent of treatment, pulse pressure, and the degree of fall in diastolic blood pressure and is unlikely to be caused by poor left ventricular function. The most probable explanation is that subjects who have severe stenosis of the coronary artery as well as hypertension have a poor coronary flow reserve, which makes the myocardium vulnerable to coronary perfusion pressures that are tolerated by patients without ischaemia, particularly at high heart rates. An optimal diastolic blood pressure (phase V) for such patients is about 85 mm Hg, though particular caution is appropriate when treating very old patients (84 and over) and patients aged 60-79 who have isolated systolic hypertension.

Full text

PDF
1227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson T. W. Re-examination of some of the Framingham blood-pressure data. Lancet. 1978 Nov 25;2(8100):1139–1141. doi: 10.1016/s0140-6736(78)92288-2. [DOI] [PubMed] [Google Scholar]
  2. Coope J., Warrender T. S. Lowering blood pressure. Lancet. 1987 Aug 29;2(8557):518–518. doi: 10.1016/s0140-6736(87)91838-1. [DOI] [PubMed] [Google Scholar]
  3. Coope J., Warrender T. S. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed) 1986 Nov 1;293(6555):1145–1151. doi: 10.1136/bmj.293.6555.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cruickshank J. M., Thorp J. M., Zacharias F. J. Benefits and potential harm of lowering high blood pressure. Lancet. 1987 Mar 14;1(8533):581–584. doi: 10.1016/s0140-6736(87)90231-5. [DOI] [PubMed] [Google Scholar]
  5. Cruickshank J. M., Thorp J. M., Zacharias F. J. Heart attacks and lowering of blood pressure. Lancet. 1987 May 16;1(8542):1154–1154. doi: 10.1016/s0140-6736(87)91717-x. [DOI] [PubMed] [Google Scholar]
  6. Dellsperger K. C., Marcus M. L. The effects of pressure-induced cardiac hypertrophy on the functional capacity of the coronary circulation. Am J Hypertens. 1988 Apr;1(2):200–207. doi: 10.1093/ajh/1.2.200. [DOI] [PubMed] [Google Scholar]
  7. Kannel W. B. Role of blood pressure in cardiovascular morbidity and mortality. Prog Cardiovasc Dis. 1974 Jul-Aug;17(1):5–24. doi: 10.1016/0033-0620(74)90034-6. [DOI] [PubMed] [Google Scholar]
  8. Klocke F. J. Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care. Circulation. 1987 Dec;76(6):1183–1189. doi: 10.1161/01.cir.76.6.1183. [DOI] [PubMed] [Google Scholar]
  9. Lew E. A. High blood pressure, other risk factors and longevity: the insurance viewpoint. Am J Med. 1973 Sep;55(3):281–294. doi: 10.1016/0002-9343(73)90130-7. [DOI] [PubMed] [Google Scholar]
  10. Mattila K., Haavisto M., Rajala S., Heikinheimo R. Blood pressure and five year survival in the very old. Br Med J (Clin Res Ed) 1988 Mar 26;296(6626):887–889. doi: 10.1136/bmj.296.6626.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pepi M., Alimento M., Maltagliati A., Guazzi M. D. Cardiac hypertrophy in hypertension. Repolarization abnormalities elicited by rapid lowering of pressure. Hypertension. 1988 Jan;11(1):84–91. doi: 10.1161/01.hyp.11.1.84. [DOI] [PubMed] [Google Scholar]
  12. Samuelsson O., Wilhelmsen L., Andersson O. K., Pennert K., Berglund G. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Göteborg, Sweden. JAMA. 1987 Oct 2;258(13):1768–1776. [PubMed] [Google Scholar]
  13. Sleight P. Blood pressures, hearts, and U-shaped curves. Lancet. 1988 Jan 30;1(8579):235–235. doi: 10.1016/s0140-6736(88)91079-3. [DOI] [PubMed] [Google Scholar]
  14. Stewart I. M. Long-term observations on high blood-pressure presenting in fit young men. Lancet. 1971 Feb 20;1(7695):355–358. doi: 10.1016/s0140-6736(71)92205-7. [DOI] [PubMed] [Google Scholar]
  15. Stewart I. M. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet. 1979 Apr 21;1(8121):861–865. doi: 10.1016/s0140-6736(79)91274-1. [DOI] [PubMed] [Google Scholar]
  16. Strandgaard S., Haunsø S. Why does antihypertensive treatment prevent stroke but not myocardial infarction? Lancet. 1987 Sep 19;2(8560):658–661. doi: 10.1016/s0140-6736(87)92444-5. [DOI] [PubMed] [Google Scholar]
  17. Waller P. C., Isles C. G., Lever A. F., Murray G. D., McInnes G. T. Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease? J Hum Hypertens. 1988 Jun;2(1):7–10. [PubMed] [Google Scholar]
  18. Wilhelmsen L., Berglund G., Elmfeldt D., Fitzsimons T., Holzgreve H., Hosie J., Hörnkvist P. E., Pennert K., Tuomilehto J., Wedel H. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens. 1987 Oct;5(5):561–572. doi: 10.1097/00004872-198710000-00009. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES